Circulation

NOVEMBER 11, 2024

Introduction:Blood pressure targets for the elderly are still controversial, there is a lack of certainty about the benefit and safety of targeting ≤ 130mmHg systolic blood pressure. of patients had cardiovascular disease, 10.9% chronic kidney disease. diabetes, and 15.5%

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. based, multidisciplinary conference addressing cardiometabolic disease prevention, management, and treatment.

CME 72

CME Education Diabetes Innovation 72

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionAtherosclerosis, the hardening and narrowing of the arteries, occurs due to the buildup of plaque on the inner walls of the arteries which can result in reduced blood flow to the organs and tissues. Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation.

Risk Factors 40

Risk Factors Blood Pressure Chest Pain Plaque 40

Stroke Journal

JANUARY 30, 2025

Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. These findings support further research into whether polygenic profiling can improve clinical decision-making in AF patients. for models without and with genomic information, respectively (p=0.01, Figure 2).Conclusions:Our

Atrial Fibrillation 40

Atrial Fibrillation Hemorrhage Risk Factors Kidney Disease 40

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

CardiacWire

OCTOBER 6, 2024

Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its blood pressure effects. Finerenone is already approved to reduce cardiovascular and kidney disease risks in patients with type 2 diabetes-associated CKD, but not for HF. in the future.

Heart Failure 59

Heart Failure Blood Pressure Kidney Disease Diabetes 59

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Cardiometabolic Health Congress

JULY 10, 2024

Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression. His work was particularly influential in understanding racial disparities in disease progression and developing targeted interventions.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

Stroke Journal

JANUARY 30, 2025

Background and Purpose:Chronic kidney disease (CKD) is associated with an increased risk of stroke and worse outcomes, yet it is often asymptomatic, with an estimated 90% of individuals unaware they have CKD until its later stages. Stroke, Volume 56, Issue Suppl_1 , Page A102-A102, February 1, 2025. female, 22.1%

Atherosclerosis 40

Atherosclerosis Kidney Disease Blood Pressure Biomarkers 40

Cardiometabolic Health Congress

JULY 25, 2023

To do this, however, you need some relatively sophisticated tools that not everybody has available in their practice, including devices to measure body composition, like bioelectrical impedance analysis (BIA), which is frequently being used in research and more recently also in clinical practice. Obesity and cardiovascular disease.”

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 29, 2025

24-h ambulatory blood pressure (BP) [systolic/diastolic (SBP/DBP)], serum creatinine (with eGFR calculation), serum adipocytokines (leptin, adiponectin, resistin), serum metanephrines and normetanephrines were measured baseline and 12 months after RDN. years) and 33 women (59.58.4 In men, the eGFR did not change.

Obesity 52

Obesity Hypertension Kidney Disease Blood Pressure 52

DAIC

JANUARY 23, 2024

7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 34 The safety of colchicine, 0.5

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Physiologically Speaking

MAY 3, 2024

Understand the molecular response to exercise is a new area of research that is being spearheaded by the Molecular Transducers of Physical Activity Consortium (MoTrPAC) , which has the goal of “developing the compendium of molecular transducers (the “molecular map”) that respond to acute and chronic exercise.”

Exercise 95

Exercise Physiology Research Kidney Disease 95

Frontiers in Cardiovascular Medicine

JANUARY 5, 2025

Patients in VERISEC were older and had more comorbidities (diabetes, advanced chronic kidney disease) compared to VICTORIA, with 20% having an estimated glomerular filtration rate below 30ml/min. Further research is needed to identify which patients may benefit the most from vericiguat treatment. Of these patients, 79.6%

Heart Failure 52

Heart Failure Kidney Disease Blood Pressure Diabetes 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. Disparities in care are also concerning, with diagnosed cardiometabolic diseases varying up to twofold among different racial and ethnic groups. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103